Moderna seeks full FDA approval of its COVID-19 vaccine
More than 124 million doses have been administered under an emergency use authorization.
Moderna submitted its coronavirus vaccine for full FDA approval.
Moderna is seeking full approval from the US Food and Drug Administration to administer its coronavirus vaccine in people 18 and older, the company said Monday. The vaccine is being given to adults in America under an emergency use authorization, which was granted in December.
Last week, the pharmaceuticals company said its vaccine is effective in 12- to 17-year-olds, and it will seek approval to administer its vaccine to teenagers this month.
More than 124 million doses of Moderna's vaccine had been administered in the US as of Monday, according to data from the Centers for Disease Control and Prevention. Rival vaccine maker Pfizer sought full approval last month, and more than 159 million doses of its vaccine have been given.
See also: 16 important do's and don'ts for getting your COVID-19 vaccine